✦ LIBER ✦

Combination chemotherapy with 254-S, ifosfamide, and peplomycin for advanced or recurrent cervical cancer

✍ Scribed by Koji Hirabayashi; Etsuko Okada

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 586 KB
Volume: 71
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19930501)71:9<2769::aid-cncr2820710914>3.0.co;2-m

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy for advanced and/or recurre

Chemotherapy for advanced and/or recurrent cervical cancer

✍ M. Lahousen; Hellmuth Pickel; Karl Tamussino 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 271 KB

Neoadjuvant chemotherapy with carboplati

Neoadjuvant chemotherapy with carboplatin, ifosfamide, and peplomycin in advanced cervical squamous cell carcinoma

✍ T. Nagano; M. Ozawa; A. Suzuki; T. Morizuka; H. Noguchi; T. Miwa; S. Okabe; T. S 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 73 KB

Combination therapy with S-1 and irinote

Combination therapy with S-1 and irinotecan (CPT-11) for advanced or recurrent gastric cancer

✍ Hiroya Takiuchi 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 178 KB

A phase II study of doxifluridine and do

A phase II study of doxifluridine and docetaxel combination chemotherapy for advanced or recurrent gastric cancer

✍ Takaki Yoshikawa; Akira Tsuburaya; Ken Shimada; Atsushi Sato; Makoto Takahashi; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 236 KB

A phase II study of irinotecan and docet

A phase II study of irinotecan and docetaxel combination chemotherapy for patients with previously treated metastatic or recurrent advanced gastric cancer

✍ Sun Jin Sym; Heung Moon Chang; Hye Jin Kang; Sung Sook Lee; Min-Hee Ryu; Jae-Lyu 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 336 KB

Combination chemotherapy with carboplati

Combination chemotherapy with carboplatin and bleomycin for advanced and recurrent head and neck cancer: A phase II study

✍ Jose L. Gonzalez-Vela; Lawrence Panasci; Martin Black; Michael Pollak; Richard M 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

Carboplatin is a platinum analogue with activity reported in head and neck cancer. We conducted a phase II trial with 14 patients who had recurrent head and neck cancer. They were treated with carboplatin 300 mg/m2 intravenously (I.V.) and bleomycin 30 units I.V. every 4 weeks. No responses were obs